【レポートの概要（一部）】
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2015 and Global Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 Defining the Human Tissue Banking Market for the Scope of this Report
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015 to 2026
3.1 The World Biobanking for Medicine Market in 2015
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2020 and 2026
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015 to 2026
3.4 Biobanks Stored More Than 1.4 Billion Specimens in 2015
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015 to 2026
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015 to 2026
3.6.2 Driving Forces: Outweighs Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015 to 2026
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015 to 2026
4. Biobanking for Research Purposes
4.1 Breakdown of Biobanking for Research Market by Tissue Type, 2015
4.2 Biobanking for Research in 2020 and 2026: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015 to 2026
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2015
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015 to 2026
4.7 The Human Tissue Banking Market: Commercial vs. Public Sectors
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015 to 2026
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015 to 2026
4.8 The Stem Cell Banking Market for Research in 2015
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015 to 2026
4.9.1 R&D- Growing Interest Towards iPSCs
4.10 Banking of Other Biologics Specimens for Research in 2015
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015 to 2026
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2015: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2020 and 2026
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cells Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2015
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015 to 2026
5.7 The Adult Stem Cell Banking Market in 2015
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015 to 2026
6. Leading National Markets 2015 to 2026
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2015
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015 to 2026
6.4 How Will Regional Market Shares Change to 2026?
6.5 The US Biobanking Market 2015 to 2026: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015 to 2026: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015 to 2026: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2026
6.8.1 The Chinese Biobanking Market 2015 to 2026: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015 to 2026: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015 to 2026: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015 to 2026?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability, Easy Sample Tracking, and Added Security
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2015
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand Bioscience is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, BioSpoke and PhaseZERO
8.2.2.2 The Future Outlook for Asterand
8.2.3 Biopta: Human Tissue Provider Now Acquired by Japanese Company ReproCELL
8.2.3.1 Services from Biopta: A Variety of Lab Services and Fresh Tissue Sample Procurement
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta: Fresh Tissue Will Be in Demand
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of and Recent Developments at Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2015
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled, Strategic Alternatives Being Considered
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences Is Under a New Owner
8.3.5 LifebankUSA: Acquisition from Human Longevity Inc Will Potentially Drive Growth
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company Will Be Promoted By New Parent Company
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Reportedly Facing Challenges Due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 Caladrius Biosciences (formerly NeoStem): More Focus on Cell Therapy Than Stem Cell Banking
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Market 2015 to 2026
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2015
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 The Effect of Big Data on Biobanking
9.2.5 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.6 Biobanks are Fragmented and Uncoordinated
9.2.7 Lack of Standardisation is a Weakness of the Industry
9.2.8 Lack of Public Awareness Limits Number of Donors
9.2.9 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015 to 2026
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long-Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015 to 2026
10. Research Interviews
10.1 Mr Veselin D. Stefanov, MBA, General Manager, Fidelis Research, Bulgaria
10.1.1 Fidelis Research – Specialists in Human Tissue Procurement With a Strong Network of Partners
10.1.2 Challenges in Tissue Procurement Stem from a Lack of Legislation
10.1.3 Lack of Standardisation Causing Decreased Demand for Biobanked Tissues
10.1.4 Significant Therapeutic Areas of Demand
10.1.5 Essential Qualities for a Successful Tissue Procurement Service
10.1.6 The Impact of Trends in Biobanking
10.2 Dr Jeanne-Hélène di Donato, 3C-R, France
10.2.1 French Biobanks – a Network of Specialized Biobanks
10.2.2 Biobanking Management –Promoting Scientific Value of Collections
10.2.3 Harmonization – Scientific Valorisation
10.2.4 Bioethical – Diverse Views and Policies on Consent
10.2.5 Broad Consent –Is This the Best Option?
10.2.6 3C-R – Services and Solutions for Biobanks
10.3 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.3.1 UK ME/CFS Biobank – Objectives and Activities
10.3.2 Biobank Resource – Available for External Researchers in August 2015
10.3.3 Main Issue – Sustainability
10.3.4 Unmet Needs – Awareness from Government and General Public
11. Conclusions from Our Research and Analysis
11.1 World Biobanking Market 2015 to 2026: High Revenue Growth Predicted
11.2 Biobanking for Research 2015 to 2026: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015 to 2026: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples – Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver and a Need for Strategic Planning for Sustainability
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：バイオバンクの世界市場予測2016-2026■ 英文：Biobanking Market Forecasts 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60628
■ 調査対象地域：グローバル
- 世界主要国におけるシュードモナス検査市場2015The report presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pseudomonas definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - …
- 自由空間光通信（FSO）の世界市場Free Space Optics (FSO) is a line-of-sight (LOS) technology that uses directed laser beams, which provide optical bandwidth Transmitters and Receivers to link voice, video, and data intelligent transfer. A single FSO link product (from point A to point B) often may incorporate multiple transmitters along with receiver/s to ensure adequate performance, in case of interference. This ElectroniCast Ex …
- 配矯正装置の世界市場分析：用途別（股関節、膝、脊柱、頭蓋 – 顎顔面、歯科、スポーツ外傷、外傷、外傷（SET））、製品タイプ別（アクセサリー、外科装置）、セグメント予測The global orthopedic devices market is expected to reach USD 43.1 billion by 2024, according to a new report published by Grand View Research, Inc. Major drivers of the market include the rising demand for orthopedic surgeries owing to the growth in road accidents and the prevalence of orthopedic diseases. The introduction of new products made of materials, such as various types of ceramics and p …
- 世界及び台湾の小型/中型TFT-LCDパネル市場規模予測The smartphone market, especially in China, has played an important role in small & medium size TFT-LCD panel shipments. However, affected by telecom operators' reduction in mobile phone subsidies and the belated issuance of 4G licenses in China, the replacement demand for 4G models did not realize in 2014. Besides, the low cost trend has brought down panel ASP despite constant improvements in spe …
- 帯電防止パッケージングの世界市場2016-2020About Anti-Static Packaging Anti-static packaging is used for devices or products that can be damaged by ESD. It is specially meant for devices that are prone to triboelectric charging. Triboelectric charging occurs due to friction between two material surfaces. The intensity of electrical charge depends on various factors such as surface roughness, strain, temperature, and other properties of the …
- トランスレーショナル再生医療の世界市場：幹細胞治療、ティッシュ・エンジニアリング治療、遺伝子治療Translational Regenerative Medicine - new study showing you trends, R&D progress, and predicted revenues Where is the market for regenerative medicine heading? What are the commercial prospects for this market and related technologies? Visiongain’s brand new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects. Visiongain’s report lets you asse …
- 電気自動車（EV）ワイヤーハーネスシステムの世界市場2017-2021About EVWHS A wiring harness is a set of wires, terminals, and connectors, which runs throughout the system that they are incorporated into. It is mainly used to relay power and communication and is the major part for the connectivity of various devices in the system. Wiring harness minimizes the complexity in connecting devices, which is finding high adoption in the automotive industry owing to t …
- 硬質プラスチック包装の世界市場：プラスチックびん、プラスチック容器About Rigid Plastic Packaging Rigid plastics are a grade of highly toughened plastics that are used for a variety of applications for the purpose of packaging of bulk and unit materials. They are non-corrosive, light, cheap, and easily moldable, which makes them a perfect choice for packaging. Processes such as extrusion molding, injection molding, and blow molding are used to produce different ri …
- 世界のアイデンティティ及びアクセス管理市場動向（2012-2016）TechNavio's analysts forecast the Global Identity and Access Management market to grow at a CAGR of 13.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing government regulatory norms. The Global Identity and Access Management market has also been witnessing an increased number of merger and acquisitions. However, the increasing complexit …
- グリッドスケールエネルギー貯蔵の世界市場2016-2020About Grid Scale Energy Storage A grid-scale energy storage system stores power when there is excess and releases energy when there is demand such as during power outage. The increased use of intermittent renewable energy sources has resulted in the use of energy storage systems. Electricity storage primarily fills the gap between the ramping down/ ramping up time of wind/ solar powered energy gen …
- 慢性リンパ性白血病（CLL）：グローバル製薬市場機会分析と予測OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled proliferation of B lymphocytes (a type of white blood cell) in the bone marrow, blood and lymphoid tissues. This report focuses on the current treatment landscape, unmet needs, pipeline and c …
- China National Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- 2012China National Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary China National Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The rep …
- 海上地震探査装置及びデータ取得の世界市場Overall, spending on marine seismic equipment and acquisition will fall significantly in 2015 after the oil price collapse and then gradually recover in line with oil prices. However it will take years to reach CAPEX levels witnessed in 2014. Visiongain has calculated that in 2015 the global marine seismic equipment market is worth $784.3m and the global acquisition market is worth $4,601.6m. What …
- 有毛細胞白血病：世界の臨床試験レビュー（2014年上半期）Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Hairy Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hairy Cell Leukemia. It includes an overview of the trial numbers and their recru …
- 食品・飲料用金属缶の世界市場予測（～2022年）The global market for food & beverage metal cans is projected to reach 551.38 Billion units in terms of volume by 2022 and USD 63.01 Billion by value and CAGR of 3.6% by 2022. The metal cans packaging industry is a key contributor to the consumer packaged goods industry. Economic development, changes in lifestyle, increase consumption of convenience food products, ease of recyclability of metal ca …
